Evaluation of Selected Parameters of the Specific Immune Response against Pseudomonas aeruginosa Strains

被引:3
作者
Dzik, Michal [1 ,2 ]
Aebisher, David [3 ]
Olender, Alina [4 ]
Tabarkiewicz, Jacek [3 ,5 ]
机构
[1] Med Univ Lublin, Fac Med, Dept Clin Immunol, PL-20095 Lublin, Poland
[2] Inst Asclepiade, F-10410 St Parres Aux Tertres, France
[3] Univ Rzeszow, Med Coll Rzeszow Univ, Ctr Innovat Res Med & Nat Sci, PL-35959 Rzeszow, Poland
[4] Med Univ Lublin, Fac Med, Chair & Dept Med Microbiol, PL-20095 Lublin, Poland
[5] Univ Rzeszow, Med Coll Rzeszow Univ, Inst Med Sci, Dept Human Immunol, PL-35959 Rzeszow, Poland
关键词
Pseudomonas aeruginosa; dendritic cells; HLA-DR; Th17; cells; RISK-FACTORS; INFECTION; PNEUMONIA; BACTEREMIA; MORTALITY;
D O I
10.3390/cells11010003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The immune response to Pseudomonas aeruginosa strains could be influenced by differences in antibiotic resistance and virulence. At the present time, it is unclear which type of immune responses enables uncontrolled invasion of opportunistic pathogens. The conditional pathogenicity of Pseudomonas aeruginosa served as an inspiration to begin a study on this bacterium. The aim of this study was to gain insight into selected parameters describing immune responses with regards to the adaptable agents of this pathogen. For the analysis of the specific immune response, the potential of Pseudomonas aeruginosa to stimulate lymphocytes, including Th17 lymphocytes, dendritic cells and other components of the adaptive immune response, was examined. The highest percentage of CD83+CD1a-HLA-DR++ cells was found after stimulation with lysates of strains isolated from the patients with severe systemic infection. We found statistically significant differences in percentages of HLA-DR+ PBMCs and MFI of HLA-DR between groups of Pseudomonas aeruginosa strains isolated from the patients with different clinical courses of infection. Our results suggest that the clinical course and outcomes of Pseudomonas aeruginosa infections are not associated with impairment of the specific immune response.
引用
收藏
页数:12
相关论文
共 19 条
[1]   Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis [J].
Avendano-Ortiz, Jose ;
Llanos-Gonzalez, Emilio ;
Toledano, Victor ;
del Campo, Rosa ;
Cubillos-Zapata, Carolina ;
Lozano-Rodriguez, Roberto ;
Ismail, Ahmad ;
Prados, Concepcion ;
Gomez-Campelo, Paloma ;
Aguirre, Luis A. ;
Garcia-Rio, Francisco ;
Lopez-Collazo, Eduardo .
JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (05) :630-635
[2]  
Bassetti M, 2012, EXPERT REV ANTI-INFE, V10, P585, DOI [10.1586/ERI.12.36, 10.1586/eri.12.36]
[3]  
Caras Iuliana, 2007, Roum Arch Microbiol Immunol, V66, P5
[4]   Catheter-Associated Urinary Tract Infection by Pseudomonas aeruginosa Is Mediated by Exopolysaccharide-Independent Biofilms [J].
Cole, Stephanie J. ;
Records, Angela R. ;
Orr, Mona W. ;
Linden, Sara B. ;
Lee, Vincent T. .
INFECTION AND IMMUNITY, 2014, 82 (05) :2048-2058
[5]  
Davies Jane C, 2002, Paediatr Respir Rev, V3, P128, DOI 10.1016/S1526-0550(02)00003-3
[6]   Pseudomonas aeruginosa pneumonia [J].
Garau, J ;
Gomez, L .
CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (02) :135-143
[7]   Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults:: Case report and review of the literature [J].
Hatchette, TF ;
Gupta, R ;
Marrie, TJ .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) :1349-1356
[8]   Corneal response to Pseudomonas aeruginosa infection [J].
Hazlett, LD .
PROGRESS IN RETINAL AND EYE RESEARCH, 2004, 23 (01) :1-30
[9]   Clinical Characteristics and Risk Factors for Mortality in Patients with Bacteremia Caused by Pseudomonas aeruginosa [J].
Horino, Tetsuya ;
Chiba, Akio ;
Kawano, Shinji ;
Kato, Tetsuro ;
Sato, Fumiya ;
Maruyama, Yukio ;
Nakazawa, Yasushi ;
Yoshikawa, Koji ;
Yoshida, Masaki ;
Hori, Seiji .
INTERNAL MEDICINE, 2012, 51 (01) :59-64
[10]   Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome [J].
Kang, CI ;
Kim, SH ;
Kim, HB ;
Park, SW ;
Choe, YJ ;
Oh, MD ;
Kim, EC ;
Choe, KW .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) :745-751